Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Arch Pediatr Adolesc Med ; 150(1): 70-3, 1996 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8542010

RESUMEN

OBJECTIVES: To determine if serum lactate dehydrogenase levels distinguish patients with malignant neoplasm presenting with musculoskeletal complaints from patients with juvenile rheumatoid arthritis who reported similar symptoms. DESIGN: Retrospective case-comparison study. SETTING: Tertiary care, outpatient clinics. PATIENTS: Twelve patients with malignant neoplasms who presented with arthritis or arthralgias and normal complete blood cell counts and blood smears in whom rheumatologic diagnosis was initially made were compared with 24 children with a final diagnosis of juvenile rheumatoid arthritis. The patients with malignant neoplasms all had normal blood counts and elevated sedimentation rates at symptom onset. INTERVENTIONS: None. RESULTS: Serum lactate dehydrogenase levels were significantly higher in the cancer patients at 2.2 times the normal values vs 0.8 times high normal for patients with juvenile rheumatoid arthritis (P =.004, Mann-Whitney U test) No significant differences were observed in white blood cell counts, hemoglobin levels, platelet counts, erythrocyte sedimentation rate, or uric acid or aspartate aminotransferase levels at initial evaluation. CONCLUSIONS: Serum lactate dehydrogenase values may distinguish patients with malignant neoplasms from those with rheumatic disease early in the course of illness when symptoms and other laboratory values are not helpful.


Asunto(s)
Artralgia/etiología , L-Lactato Deshidrogenasa/sangre , Neoplasias/diagnóstico , Neoplasias/enzimología , Adolescente , Artralgia/enzimología , Artritis Juvenil/diagnóstico , Artritis Juvenil/enzimología , Recuento de Células Sanguíneas , Sedimentación Sanguínea , Niño , Preescolar , Diagnóstico Diferencial , Análisis Discriminante , Femenino , Estudios de Seguimiento , Humanos , Masculino , Neoplasias/complicaciones , Estudios Retrospectivos
2.
Alcohol Clin Exp Res ; 16(3): 474-9, 1992 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1626648

RESUMEN

Treatment of mice in vivo with 5% w/v ethanol given in a liquid diet causes marked changes in spleen, peripheral blood, and thymus lymphocytes. In both the thymus and spleen, there is an acute cellular depletion resulting in a significant decrease in gross tissue size and cell number. In spleen and peripheral blood, the percentage of T lymphocytes is increased relative to B lymphocytes, but the ratio of CD4+/CD8+ T cell sub-populations remains unchanged. Splenic natural killer (NK) cell activity is increased in ethanol-consuming mice, although the percentage of NK1.1+ cells is relatively unchanged.


Asunto(s)
Consumo de Bebidas Alcohólicas/inmunología , Alcoholismo/inmunología , Células Asesinas Naturales/inmunología , Subgrupos Linfocitarios/inmunología , Animales , Citotoxicidad Inmunológica/inmunología , Etanol/farmacocinética , Recuento de Leucocitos/efectos de los fármacos , Hígado/inmunología , Complejo Mayor de Histocompatibilidad/inmunología , Ratones , Ratones Endogámicos , Bazo/inmunología , Timo/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA